Understanding barriers to utilization of 17-hydroxyprogesterone caproate and other interventions to prevent preterm birth in Fresno County, California
Subhashini Ladella,Amber Shaver,Tania Pacheco-Werner,Cynthia Cortez,Mallory Novack,Andrea Wiemann,Miriam KuppermannArticle info
Understanding barriers to utilization of 17-hydroxyprogesterone caproate and other interventions to prevent preterm birth in Fresno County, California. Perinatal Journal 2021;29(2):155-164 DOI: 10.2399/prn.21.0292011
Author(s) Information
Subhashini Ladella (Project Initiator, Study Designer, Study Supervisor, Results Interpreter, Literature Researcher, Manuscript Writer, Final Reviewer) Amber Shaver (Study Designer, Data Analyst, Results Interpreter, Literature Researcher, Manuscript Writer) Tania Pacheco-Werner (Project Initiator, Data Analyst, Results Interpreter, Manuscript Writer) Cynthia Cortez (Study Supervisor, Data Collector, Literature Researcher, Manuscript Writer, Final Reviewer) Mallory Novack (Study Supervisor, Literature Researcher, Manuscript Writer) Andrea Wiemann (Study Designer, Data Analyst, Results Interpreter) Miriam Kuppermann (Project Initiator, Study Supervisor, Results Interpreter, Manuscript Writer, Final Reviewer)Correspondence
Subhashini Ladella, Department of Obstetrics & Gynecology, Maternal Fetal Medicine, University of California San Francisco-Fresno, Fresno, CA, USA, Subhashini.Ladella@ucsf.edu
Publication History
- Manuscript Received: June 01, 2021
- Manuscript Accepted: August 01, 2021
- Earlyview Date: August 01, 2021
- Publication date: September 10, 2021
Conflicts of Interest
Funding: This work did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Compliance with Ethical Standards
The authors stated that the standards regarding research and publication ethics, the Personal Data Protection Law and the copyright regulations applicable to intellectual and artistic works are complied with and there is no conflict of interest.